- Markets
- Trading
- REMLIFE
REMLIFE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Remedium Lifecare To Raise Up To 500 Mln Rupees Via Rights Issue
Jan 22 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO RAISE UP TO 500 MILLION RUPEES VIA RIGHTS ISSUE
Source text: ID:nBSEXmjnS
Further company coverage: REMU.BO
(([email protected];;))
Jan 22 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO RAISE UP TO 500 MILLION RUPEES VIA RIGHTS ISSUE
Source text: ID:nBSEXmjnS
Further company coverage: REMU.BO
(([email protected];;))
Remedium Lifecare Denies Receiving Order From Eli Lilly
Jan 7 (Reuters) - Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE LTD - DENIES RECEIVING ORDER FROM ELI LILLY
REMEDIUM LIFECARE - CALLS MEDIA REPORTS CLAIMING CO GOT ORDER FROM ELI LILLY SPECULATIVE, UNFOUNDED
Source text: ID:nBSE4r2PMk
Further company coverage: REMU.BO
(([email protected];))
Jan 7 (Reuters) - Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE LTD - DENIES RECEIVING ORDER FROM ELI LILLY
REMEDIUM LIFECARE - CALLS MEDIA REPORTS CLAIMING CO GOT ORDER FROM ELI LILLY SPECULATIVE, UNFOUNDED
Source text: ID:nBSE4r2PMk
Further company coverage: REMU.BO
(([email protected];))
Remedium Lifecare To Raise Funds Up To $25 Mln
Sept 4 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO RAISE FUNDS UP TO $25 MILLION
Source text for Eikon: ID:nBSE2lHP2l
Further company coverage: REMU.BO
(([email protected];;))
Sept 4 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO RAISE FUNDS UP TO $25 MILLION
Source text for Eikon: ID:nBSE2lHP2l
Further company coverage: REMU.BO
(([email protected];;))
Remedium Lifecare To Consider Acquisition Of Co In Specialty Chemicals Sector
July 15 (Reuters) - Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE - TO CONSIDER ACQUISITION OF CO IN SPECIALTY CHEMICALS SECTOR
REMEDIUM LIFECARE LTD - ACQUISITION VALUE EXPECTED TO BE AROUND 10 BILLION RUPEES
Source text for Eikon: ID:nBSE1RqyGK
Further company coverage: REMU.BO
(([email protected];))
July 15 (Reuters) - Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE - TO CONSIDER ACQUISITION OF CO IN SPECIALTY CHEMICALS SECTOR
REMEDIUM LIFECARE LTD - ACQUISITION VALUE EXPECTED TO BE AROUND 10 BILLION RUPEES
Source text for Eikon: ID:nBSE1RqyGK
Further company coverage: REMU.BO
(([email protected];))
Remedium Lifecare Gets Supply Contract From Pharmac Distribution Co In United Kingdom
June 25 (Reuters) - Remedium Lifecare Ltd REMU.BO:
RECEIVED MULTI-YEAR SUPPLY CONTRACT FROM PHARMACEUTICAL DISTRIBUTION CO IN UNITED KINGDOM
CONTRACT INVOLVES SUPPLY OF ACTIVE PHARMACEUTICAL INGREDIENTS, INTERMEDIATES, AND SPECIALTY CHEMICALS
SUPPLIES SCHEDULED BETWEEN JULY 2024 AND JUNE 2025 VALUED AT 1.75 BILLION RUPEES
Source text for Eikon: ID:nBSE7M9jBH
Further company coverage: REMU.BO
(([email protected];))
June 25 (Reuters) - Remedium Lifecare Ltd REMU.BO:
RECEIVED MULTI-YEAR SUPPLY CONTRACT FROM PHARMACEUTICAL DISTRIBUTION CO IN UNITED KINGDOM
CONTRACT INVOLVES SUPPLY OF ACTIVE PHARMACEUTICAL INGREDIENTS, INTERMEDIATES, AND SPECIALTY CHEMICALS
SUPPLIES SCHEDULED BETWEEN JULY 2024 AND JUNE 2025 VALUED AT 1.75 BILLION RUPEES
Source text for Eikon: ID:nBSE7M9jBH
Further company coverage: REMU.BO
(([email protected];))
Remedium Lifecare To Acquire Manufacturing Facility In Hyderabad For 380 Mln Rupees
March 7 (Reuters) - Remedium Lifecare Ltd REMU.BO:
PROPOSED TO ACQUIRE A MANUFACTURING FACILITY IN HYDERABAD
MANUFACTURING UNIT DEAL FOR 380 MILLION RUPEES
WITH THIS ACQUISITION, CO WILL BRANCH INTO MANUFACTURING OF PHARMACEUTICAL INTERMEDIATES
EXPECT TO CLOSE TRANSACTION WITHIN 30TH JUNE 2024
Source text for Eikon: ID:nBSE6nC1J6
Further company coverage: REMU.BO
(([email protected];))
March 7 (Reuters) - Remedium Lifecare Ltd REMU.BO:
PROPOSED TO ACQUIRE A MANUFACTURING FACILITY IN HYDERABAD
MANUFACTURING UNIT DEAL FOR 380 MILLION RUPEES
WITH THIS ACQUISITION, CO WILL BRANCH INTO MANUFACTURING OF PHARMACEUTICAL INTERMEDIATES
EXPECT TO CLOSE TRANSACTION WITHIN 30TH JUNE 2024
Source text for Eikon: ID:nBSE6nC1J6
Further company coverage: REMU.BO
(([email protected];))
Remedium Lifecare Got Export Order Of 1.69 Billion Rupees
Feb 28 (Reuters) - Remedium Lifecare Ltd REMU.BO:
GOT EXPORT ORDER OF 1.69 BILLION RUPEES FROM PHARMYKA GENERAL TRADING LLC
Further company coverage: REMU.BO
(([email protected];))
Feb 28 (Reuters) - Remedium Lifecare Ltd REMU.BO:
GOT EXPORT ORDER OF 1.69 BILLION RUPEES FROM PHARMYKA GENERAL TRADING LLC
Further company coverage: REMU.BO
(([email protected];))
Remedium Lifecare To Consider Acquisition Of Manufacturing Facility
Feb 23 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO CONSIDER ACQUISITION OF MANUFACTURING FACILITY NEAR HYDERABAD
Source text for Eikon: ID:nBSE3rk5p6
Further company coverage: REMU.BO
(([email protected];;))
Feb 23 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO CONSIDER ACQUISITION OF MANUFACTURING FACILITY NEAR HYDERABAD
Source text for Eikon: ID:nBSE3rk5p6
Further company coverage: REMU.BO
(([email protected];;))
Remedium Lifecare Dec-Qtr Profit Rises
Feb 14 (Reuters) - Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE DEC-QUARTER PROFIT 687.8 MILLION RUPEES VERSUS PROFIT 15.2 MILLION RUPEES
REMEDIUM LIFECARE DEC-QUARTER REVENUE FROM OPERATIONS 18.34 BILLION RUPEES VERSUS 1.76 BILLION RUPEES
Source text for Eikon: ID:nBSE2DDtCQ
Further company coverage: REMU.BO
(([email protected];;))
Feb 14 (Reuters) - Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE DEC-QUARTER PROFIT 687.8 MILLION RUPEES VERSUS PROFIT 15.2 MILLION RUPEES
REMEDIUM LIFECARE DEC-QUARTER REVENUE FROM OPERATIONS 18.34 BILLION RUPEES VERSUS 1.76 BILLION RUPEES
Source text for Eikon: ID:nBSE2DDtCQ
Further company coverage: REMU.BO
(([email protected];;))
Remedium Lifecare Ltd- To Consider And Approve Sub-Division Of Shares
Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE LTD- TO CONSIDER AND APPROVE SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE34VZ2s
Further company coverage: REMU.BO
Remedium Lifecare Ltd REMU.BO:
REMEDIUM LIFECARE LTD- TO CONSIDER AND APPROVE SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE34VZ2s
Further company coverage: REMU.BO
Remedium Lifecare To Consider Issue Of Bonus Shares
June 14 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO CONSIDER ISSUE OF BONUS SHARES
TO CONSIDER INCREASING BORROWING LIMIT FROM 500 MILLION RUPEES TO 10 BILLION RUPREES BY ISSUANCE OF DEBT SECURITIES
TO CONSIDER LIMIT FOR INVESTMENT VIA ACQUISITION OF ASSET UPTO 10 BLN RUPEES
TO CONSIDER SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE4TDrQf
Further company coverage: REMU.BO
(([email protected];))
June 14 (Reuters) - Remedium Lifecare Ltd REMU.BO:
TO CONSIDER ISSUE OF BONUS SHARES
TO CONSIDER INCREASING BORROWING LIMIT FROM 500 MILLION RUPEES TO 10 BILLION RUPREES BY ISSUANCE OF DEBT SECURITIES
TO CONSIDER LIMIT FOR INVESTMENT VIA ACQUISITION OF ASSET UPTO 10 BLN RUPEES
TO CONSIDER SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE4TDrQf
Further company coverage: REMU.BO
(([email protected];))
Upcoming Events:
e-Voting
Events:
Rights
Bonus
Split
Split
Bonus
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Remedium Lifecare do?
Remedium Lifecare Ltd. is a pharmaceutical company specializing in the manufacture and sale of APIs and Intermediates for innovator and generic pharmaceutical players in domestic and international markets.
Who are the competitors of Remedium Lifecare?
Remedium Lifecare major competitors are Abate AS Industries, Maximus Internatl., MRP Agro Ltd., Newjaisa Tech, Thacker & Co, Sizemasters Technolg, Emergent Ind Soln. Market Cap of Remedium Lifecare is ₹152 Crs. While the median market cap of its peers are ₹152 Crs.
Is Remedium Lifecare financially stable compared to its competitors?
Remedium Lifecare seems to be less financially stable compared to its competitors. Altman Z score of Remedium Lifecare is 2.2 and is ranked 7 out of its 8 competitors.
Does Remedium Lifecare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Remedium Lifecare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Remedium Lifecare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Accounts Receivable
How strong is Remedium Lifecare balance sheet?
Balance sheet of Remedium Lifecare is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Remedium Lifecare improving?
The profit is oscillating. The profit of Remedium Lifecare is -₹49.55 Crs for TTM, ₹32.73 Crs for Mar 2024 and ₹5.43 Crs for Mar 2023.
Is the debt of Remedium Lifecare increasing or decreasing?
Yes, The debt of Remedium Lifecare is increasing. Latest debt of Remedium Lifecare is ₹176 Crs as of Sep-24. This is greater than Mar-24 when it was ₹54.93 Crs.
Is Remedium Lifecare stock expensive?
Remedium Lifecare is not expensive. Latest PE of Remedium Lifecare is 0.0, while 3 year average PE is 59.5. Also latest EV/EBITDA of Remedium Lifecare is 0.0 while 3yr average is 41.5.
Has the share price of Remedium Lifecare grown faster than its competition?
Remedium Lifecare has given lower returns compared to its competitors. Remedium Lifecare has grown at ~-91.12% over the last 1yrs while peers have grown at a median rate of -11.36%
Is the promoter bullish about Remedium Lifecare?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Remedium Lifecare is 1.11% and last quarter promoter holding is 1.11%.
Are mutual funds buying/selling Remedium Lifecare?
There is Insufficient data to gauge this.